# Karl Swedberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/karl-swedberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 102,045 |
| Field | Heart Failure Treatment and Management |
| h-index | 137 |
| i10-index | 456 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5085843860 |
| ORCID iD | 0000-0002-6358-2154 |
| Works | 689 |

## Researcher papers

Showing 12 of 33.

- [Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-versus-enalapril-in-heart-failure/)
- [Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)](https://scholariq.org/papers/effects-of-enalapril-on-mortality-in-severe-congestive-heart-failure-results-of/)
- [ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-3/)
- [Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms](https://scholariq.org/papers/eplerenone-in-patients-with-systolic-heart-failure-and-mild-symptoms/)
- [Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial](https://scholariq.org/papers/effects-of-candesartan-in-patients-with-chronic-heart-failure-and-preserved-left/)
- [Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial](https://scholariq.org/papers/effects-of-candesartan-in-patients-with-chronic-heart-failure-and-reduced-left/)
- [Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study](https://scholariq.org/papers/ivabradine-and-outcomes-in-chronic-heart-failure-shift-a-randomised-placebo/)
- [Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both](https://scholariq.org/papers/valsartan-captopril-or-both-in-myocardial-infarction-complicated-by-heart/)
- [Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-chronic-heart-failure-executive/)
- [Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme](https://scholariq.org/papers/effects-of-candesartan-on-mortality-and-morbidity-in-patients-with-chronic-heart/)
- [Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial](https://scholariq.org/papers/comparison-of-carvedilol-and-metoprolol-on-clinical-outcomes-in-patients-with/)
- [Person-Centered Care — Ready for Prime Time](https://scholariq.org/papers/person-centered-care-ready-for-prime-time/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Heart rate and cardiovascular health](https://scholariq.org/topics/heart-rate-and-cardiovascular-health/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.